The prospect of an Oc­to­ber OK large­ly closed, Pfiz­er's Al­bert Bourla promis­es not to sub­mit for EUA un­til No­vem­ber

For weeks in late sum­mer and ear­ly fall, Pfiz­er CEO Al­bert Bourla in­sist­ed they would like­ly know whether their vac­cine works by the end of Oc­to­ber and then “im­me­di­ate­ly” sub­mit for an FDA OK, fu­el­ing con­cerns that Pres­i­dent Trump could push through a po­lit­i­cal­ly mo­ti­vat­ed EUA on the eve of Elec­tion Day. But now, in the lat­est of a se­ries of moves that ap­peared de­signed to dis­tance his com­pa­ny from a po­ten­tial po­lit­i­cal mael­strom, Bourla has made clear they won’t go to reg­u­la­tors for about an­oth­er month.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER